Regeneron, gene therapy
Toddler born deaf can hear after gene therapy trial breakthrough her parents call "mind-blowing"
The parents of a U.K. toddler say it's "absolutely mind-blowing" to see their daughter, enrolled in a gene therapy trial, hear for the first time.
Gene therapy brings hearing to baby girl born deaf
Opal Sandy was born into a world she could not hear. The British baby girl, now 18 months old, had a rare genetic condition called auditory neuropathy that interrupted nerve impulses that travel from the inner ear to the brain.
Gene therapy breakthrough allows toddler born deaf to hear
A British toddler born with a genetic condition resulting in deafness can now hear in one ear thanks to a pioneering new gene therapy treatment.
More children gain hearing as gene therapy for profound deafness advances
Enlarge / Opal Sandy (center), who was born completely deaf because of a rare genetic condition, can now hear unaided for the first time after receiving gene therapy at 11-months-old. She is shown with her mother, father, and sister at their home in Eynsham, Oxfordshire, on May 7, 2024.
Deaf baby hears for the first time after ‘groundbreaking’ gene therapy trial
Opal Sandy, an 18-month-old from England, is the youngest child to come close to “normal hearing levels” in a gene therapy trial to aid her genetic deafness.
Baby Girl Born Deaf Gains Hearing After Gene Therapy
The gene therapy Opal received involved the transmission into her right ear of a working copy of the OTOF gene, delivered during surgery into the ear's cochlea via a harmless virus called AAV1. The baby girl was also fitted out with a cochlear implant in her left ear.
Regeneron's experimental gene therapy improves hearing in one patient
Regeneron Pharmaceuticals said on Wednesday its investigational gene therapy improved hearing to normal levels in a child within 24 weeks in an early to mid-stage study.
Regeneron gene therapy improves hearing in child deafness
Regeneron (NASDAQ:REGN) announced Wednesday that a child who received its gene therapy candidate DB-OTO improved hearing to normal levels within 24 weeks in a Phase 1/2 trial for genetically linked deafness.
Little Opal can now hear thanks to groundbreaking gene therapy
Opal's parents, Jo and James Sandy, both 33, said they were 'gobsmacked' when they realised she could hear just weeks after the surgery.
Scientific American2h
AI Therapy Bots Have Risks and Benefits and More Risks
Therapy chatbots are increasingly popular and may benefit some people, but it's dangerous to trust AI during a mental health ...
Catch up on the day’s stories: Cheap gym memberships, Chevy’s last sedan, psychedelic therapy
2️⃣ Chevy’s last sedan: The Malibu will be phased out in a few months so the factory can shift gears and make electric ...
FDA To Hold Advisory Committee Meeting On MDMA Therapy For PTSD, Welcomes Public Comment
Another significant move forward for MDMA-assisted therapy being made available to patients suffering from PTSD ...
As Ozzy Osbourne announces stem cell therapy, experts urge caution, highlight risks
As rock legend Ozzy Osbourne has turned to stem cell therapy, some experts caution that the treatment is not for everyone. A ...
Hyperbaric Oxygen Therapy saves man from getting leg and foot amputated: All about the therapy
Ken Leslie, from Chicago, underwent hyperbaric oxygen therapy at Ingalls Memorial Hospital, preventing potential amputation ...
Merck's endometrial cancer therapy fails trial
Merck said on Thursday its therapy did not meet the main goal of disease-free survival in certain patients with endometrial ...